Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates Zacks Equity Research - Zacks Investment Research - Thu Aug 6, 12:25PM CDT Zacks Equity Research - ZACKS - Thu Aug 6, 12:25PM CDT
Bristol Myers (BMY) delivered earnings and revenue surprises of 11.64% and 0.44%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Bristol-Myer Sqb Set to Possibly Pullback After Yesterday's Rally of 3.20% Comtex SmarTrend(R) - Thu Aug 6, 11:50AM CDT CMTX - Thu Aug 6, 11:50AM CDT
Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $60.42 to a high of $62.97. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of...
Bristol Myers: 2Q Earnings Snapshot APAI - Thu Aug 6, 11:22AM CDT APAI - Thu Aug 6, 11:22AM CDT
NEW YORK (AP) _ Bristol Myers Squibb Co. (BMY) on Thursday reported a second-quarter loss of $85 million, after reporting a profit in the same period a year earlier.
Bristol-Myers (BMY) Q2 Earnings Beat, 2020 Earnings View Up Zacks Equity Research - Zacks Investment Research - Thu Aug 6, 8:57AM CDT Zacks Equity Research - ZACKS - Thu Aug 6, 8:57AM CDT
Bristol-Myers (BMY) beats on earnings and sales in the second quarter on the strength of Revlimid and Eliquis.
Global PD-L1 NSCLC Market: Insights, Epidemiology, Drugs and Players (2017-2030) PR Newswire - PRF - Thu Aug 6, 7:30AM CDT CMTX - Thu Aug 6, 7:30AM CDT
, /PRNewswire/ -- The drug pipelines has been added to offering.
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results BusinessWire - Thu Aug 6, 5:59AM CDT CMTX - Thu Aug 6, 5:59AM CDT
Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance.
bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress BusinessWire - Wed Aug 5, 3:10PM CDT CMTX - Wed Aug 5, 3:10PM CDT
--- Elivaldogene autotemcel (eli-cel, Lenti-D gene therapy) in cerebral adrenoleukodystrophy (CALD) granted accelerated assessment of Marketing Authorization Application (MAA) from EMA -
Corcept (CORT) Q2 Earnings Top Estimates, Revenues Miss Mark Zacks Equity Research - Zacks Investment Research - Wed Aug 5, 1:11PM CDT Zacks Equity Research - ZACKS - Wed Aug 5, 1:11PM CDT
Corcept's (CORT) earnings trump estimates for the second quarter of 2020 while revenues fall shy of the same.
Want To Retire Early? Learn the Intelligent Investing Secret - August 05, 2020 Zacks Equity Research - Zacks Investment Research - Wed Aug 5, 11:04AM CDT Zacks Equity Research - ZACKS - Wed Aug 5, 11:04AM CDT
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments,...
MEI Pharma (MEIP) to Report Q4 Earnings: What's in the Cards? Zacks Equity Research - Zacks Investment Research - Wed Aug 5, 10:34AM CDT Zacks Equity Research - ZACKS - Wed Aug 5, 10:34AM CDT
MEI Pharma (MEIP) will provide financial updates when it reports fourth-quarter fiscal 2020 results.
Grab These 4 High Earnings Yield Stocks for Solid Returns Zacks Equity Research - Zacks Investment Research - Wed Aug 5, 7:49AM CDT Zacks Equity Research - ZACKS - Wed Aug 5, 7:49AM CDT
While comparing stocks, if other factors are similar, the stock with a higher earnings yield is considered undervalued.
Is a Surprise Coming for Bristol-Myers (BMY) This Earnings Season? Zacks Equity Research - Zacks Investment Research - Wed Aug 5, 7:42AM CDT Zacks Equity Research - ZACKS - Wed Aug 5, 7:42AM CDT
Bristol-Myers (BMY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Next Support Level for Bristol-Myer Sqb (BMY) is $58.54 Comtex SmarTrend(R) - Tue Aug 4, 9:23AM CDT CMTX - Tue Aug 4, 9:23AM CDT
Bristol-Myer Sqb (NYSE:BMY) has opened bearishly below the pivot of $59.23 today and has reached the first level of support at $58.82. Should the shares continue to fall, the support pivots of $58.54...
Aldeyra (ALDX) to Report Q2 Earnings: What's in the Offing? Zacks Equity Research - Zacks Investment Research - Tue Aug 4, 9:07AM CDT Zacks Equity Research - ZACKS - Tue Aug 4, 9:07AM CDT
Aldeyra's (ALDX) pipeline progress will be in focus when it reports Q2 results later in the week.
Will Eliquis, Revlimid Drive Bristol-Myers (BMY) Q2 Earnings? Zacks Equity Research - Zacks Investment Research - Tue Aug 4, 9:04AM CDT Zacks Equity Research - ZACKS - Tue Aug 4, 9:04AM CDT
Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2020 results.
Orphan Drugs Market to Reach USD 340.84 Billion by 2027; Increasing Incidence of Life-threatening Diseases will Bode well for Market Growth, says Fortune Business Insights(TM) GlobeNewswire - Tue Aug 4, 8:43AM CDT CMTX - Tue Aug 4, 8:43AM CDT
The global orphan drugs market size is projected to reach USD 340.84 billion by the end of 2027. Increasing number of regulatory approvals will have a positive impact on the growth of the overall market...
3 Reasons Why Growth Investors Shouldn't Overlook Bristol Myers (BMY) Zacks Equity Research - Zacks Investment Research - Mon Aug 3, 11:45AM CDT Zacks Equity Research - ZACKS - Mon Aug 3, 11:45AM CDT
Bristol Myers (BMY) possesses solid growth attributes, which could help it handily outperform the market.
Is a Beat in the Cards for Bristol-Myers' (BMY) Q2 Earnings? Zacks Equity Research - Zacks Investment Research - Mon Aug 3, 10:46AM CDT Zacks Equity Research - ZACKS - Mon Aug 3, 10:46AM CDT
Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2020 results.
BMY vs. HZNP: Which Stock Should Value Investors Buy Now? Zacks Equity Research - Zacks Investment Research - Mon Aug 3, 10:40AM CDT Zacks Equity Research - ZACKS - Mon Aug 3, 10:40AM CDT
BMY vs. HZNP: Which Stock Is the Better Value Option?
Signs That Your Trading Will Ruin Your Retirement - August 03, 2020 Zacks Equity Research - Zacks Investment Research - Mon Aug 3, 10:05AM CDT Zacks Equity Research - ZACKS - Mon Aug 3, 10:05AM CDT
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
